Paulson Richard A. bought KPTI
October 15, 2025 · Form 4 insider transaction
Paulson Richard A. bought 114,285 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
114,285
Price
$0.00
Total value
N/A
InsiderPaulson Richard A.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 15, 2025
Filing dateOctober 16, 2025
Shares owned after198,331
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026.